Community Pharmacy England (CPE) - News updates

The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 November 2024. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution [...] The post Drug Tariff Watch – November 2024 appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (22/10/2024) announced the following list of price concessions for October 2024: Drug Pack size Price concession Aqueous cream 100 £1.11 Clarithromycin 125mg/5ml oral suspension 70 £4.72 Clotrimazole 500mg [...] The post October 2024 Price Concessions – 3rd Update appeared first on Community Pharmacy England.

Drug alert number: EL(24)A/52 Date issued: 29 October 2024 Tillomed Laboratories Limited is recalling one batch of Labetalol 200mg Tablets as a precautionary measure due to potential mix-up at the manufacturing site. DMRC Number: DMRC-33718718 SNOMED Code: 36537111000001109 Batch Number  Expiry Date Pack Size First Distributed 240537 02/2027 56 (4×14)  21/05/2024 Active Pharmaceutical Ingredient: Labetalol [...] The post MHRA Class 2 Medicines Recall: Labetalol 200mg Tablets (Tillomed Laboratories Limited) appeared first on Community Pharmacy England.

More than 1.3 million unfunded consultations a week – or just over 69 million a year – are now being carried out by community pharmacy teams in England, according to Community Pharmacy England’s 2024 Pharmacy Advice Audit. This is nearly 50% more consultations than in 2020, and is despite the introduction of the Pharmacy First [...] The post Pharmacies in England provide nearly 70 million unfunded consultations a year appeared first on Community Pharmacy England.

iNews The findings from Community Pharmacy England’s 2024 Pharmacy Advice Audit, released today, highlight that pharmacies are providing several million walk-in consultations each year. Our report shows the scale of underfunded work pharmacies are taking on, including the number of GP appointments they are saving the NHS annually, and the huge demand pharmacies in England [...] The post Pharmacies are saving the NHS 38 million GP appointments a year appeared first on Community Pharmacy England.

Community Pharmacy England has released a series of resources to help further promote the Flu Vaccination Service to patients and members of the public. Community pharmacy owners and their teams are working extremely hard to provide the flu vaccination service in a more compressed time scale this year. The change in the timing follows clinical [...] The post Flu vac: resources to promote the service appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Information: Parasolve (Paracetamol) 500mg effervescent tablets (Kent Pharma UK) Drug alert number: EL (24)A/51 Date issued: 28 October 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Parasolve (Paracetamol) 500mg effervescent tablets (Kent Pharma UK) Company name: Kent Pharma UK Product [...] The post MHRA Class 4 Medicines Defect Information: Parasolve (Paracetamol) 500mg effervescent tablets (Kent Pharma UK) appeared first on Community Pharmacy England.

As we celebrate Black History Month, we recognise the important contributions of Black colleagues across our sector. This month honours Black history, achievements and experiences, but it has also provided us a time to reflect and reaffirm our dedication to equality, diversity, and inclusion (EDI). Our Chief Executive Janet Morrison said: “At Community Pharmacy England, [...] The post Honouring Black History Month and EDI appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 18 Issue 3 October 2024) has been published and includes articles on: GLP-1 receptor agonists: reminder of the potential side effects and to be aware of the potential for misuse. Insulin pumps and continuous glucose monitoring (CGM) equipment: guidance for users on [...] The post MHRA: Drug Safety Update: October 2024 appeared first on Community Pharmacy England.

Minister Stephen Kinnock recently responded to a Parliamentary Question regarding pharmacy reimbursement. In his response, he stated that pharmacies were allowed to retain £850m medicine margin in the year 2023/24. The pharmacy funding settlement for 2022/23 and 2023/24 included an uplift to the Drug Tariff, as £100m in excess margin earned by the sector in [...] The post Clarification regarding retained margin in 2023/24 appeared first on Community Pharmacy England.